Redox imbalance in the critically ill

British Medical Bulletin

Volumn 55, Issue 1, 1999, Pages 49-75

  Gutteridge, John M C ^a   Mitchell, Jane ^b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE AGENT; NITRIC OXIDE SYNTHASE INHIBITOR; NITROGEN; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE;

CAUSE OF DEATH; CELL ADHESION; CRITICAL ILLNESS; HUMAN; HYPOTENSION; INFLAMMATORY CELL; INTENSIVE CARE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASCULAR ENDOTHELIUM; VASODILATATION;

CARDIOPULMONARY BYPASS; CRITICAL ILLNESS; HUMANS; NITROGEN OXIDES; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; RESPIRATORY DISTRESS SYNDROME, ADULT; SHOCK, SEPTIC; SIGNAL TRANSDUCTION;

EID: 0033052884     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1258/0007142991902295     Document Type: Review

References (115)

1. Gutteridge JMC, Halliwell B. Anti-oxidants in nutrition, health and disease. Oxford: Oxford University Press, 1994
2. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine, 3rd edn. Oxford: Oxford University Press, 1999
3. Halliwell B, Gutteridge JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986; 246: 501-14
4. Saran M, Bors W. Oxygen radicals acting as chemical messengers: a hypothesis. Free Radic Res Commun 1989; 7: 213-20
5. Gutteridge JMC, Paterson SK, Segal AW, Halliwell B. Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. Biochem J 1981; 199: 259-61
6. McCord JM, Fridovich I. Superoxide dismutase. An enzymatic function or erythrocuprein (hemocuprein). J Biol Chem 1969; 24: 6045-55
7. Marklund SL, Holme E, Hellner L. Superoxide dismutase in extracellular fluids. Clin Chim Acta 1982; 126: 41-51
8. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605
9. Gutteridge JMC. The membrane effects of vitamin E, cholesterol and their acetates on peroxidative susceptibility. Res Commun Chem Path Pharmacol 1978; 22: 563-71
10. Gutteridge JMC, Stocks J. Peroxidation of cell lipids. J Med Lab Sci 1976; 53: 281-5
11. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128
12. Burton GW, Joyce A, Ingold KU. First proof that vitamin E is major lipid soluble, chain-breaking anti-oxidant in human blood plasma. Lancet 1982; ii: 327
13. Stocks J, Gutteridge JMC, Sharp RJ, Dormandy TL. The inhibition of lipid antioxidation by human serum and its relation to serum proteins and α-tocopherol. Clin Sci Mol Med 1974; 47: 223-33
14. Barber AA. Inhibition of lipid peroxide formation by vertebrate blood serum. Arch Biochem Biophys 1961; 92: 38-43
15. Gutteridge JMC, Quinlan GJ. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. Biochim Biophys Acta 1992; 1159: 248-54
16. Gutteridge JMC, Stocks J. Caeruloplasmin: physiological and pathological perspectives. Crit Rev Clin Lab Sci 1981; 14: 257-329
17. Wills ED. Mechanisms of lipid peroxide formation in tissues. Role of metals and haematin proteins in the catalysis of the oxidation of unsarurated fatty acids. Biochim Biophys Acta 1965; 98: 238-51
18. Gutteridge JMC. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 1986; 201: 291-5
19. Gutteridge JMC. The anti-oxidant activity of haptoglobins towards haemoglobin stimulated lipid peroxidation. Biochim Biophys Acta 1987; 219: 219-23
20. Smith A, Morgan WT. Haem transport to the liver by haemopexin: receptor-mediated uptake with recycling of the protein. Biochem J 1979; 182: 47-54
21. Gutteridge JMC, Smith A. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem J 1988; 256: 261-5
22. Halliwell B. Albumin - an important extracellular anti-oxidant? Biochem Pharmacol 1988; 37: 569-71
23. Krinsky NI. Mechanism of action of biological anti-oxidants. Proc Soc Exp Biol Med 1992; 200: 248-54
24. Babior BM. Oxygen-dependent microbial killing by phagocytes. N Engl J Med 1978; 298: 721-5
25. Candeias LP, Patel KB, Stratford MRL, Wardman P. Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett 1993; 333: 151-3
26. Candeias LP, Stratford MRL, Wardman P. Formation of hydroxyl radicals on reaction of hypochlorous acid with ferrocyanite. A model iron (II) complex. Free Radic Res 1994; 20: 241-9
27. Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc 1894; 64: 899-909
28. Symons MCR, Gutteridge JMC. Free radicals and iron: chemistry, biology and medicine. Oxford: Oxford University Press, 1998
29. Thomas HV, Mueller PK, Lyman RL. Lipoperoxidation of lung lipids in rats exposed to nitrogen dioxide. Science 1968; 159: 532-4
30. Moncada S, Higgs EA. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 1991; 21: 361-74
31. Huie RE, Padmaja S. The reaction of NO' with superoxide. Free Radic Res Commun 1993; 18: 195-9
32. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995; 268: L699-722
33. Kaur H, Whiteman M, Halliwell B. Peroxynitrite-dependent aromatic hydroxylation and nitration of salicylate and phenlyalanine. Is hydroxyl radical involved? Free Radic Res 1997; 26: 71-82
34. Schrenk R, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress-responsible transcription factor of eukaryotic cells (review). Free Radic Res Commun 1992; 17: 221-37
35. Peng HB, Libby P. Liao JK. Induction and stabilization of I kappa B alpha by NO mediates inhibition of NF-kapa B. J Biol Chem 1995; 270: 14214-9
36. Laurindo FR, da Luz PL, Vint L, Rocha TF, Jaeger RG, Lopes EA. Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation 1991; 83: 1705-15
37. Halliwell B. Superoxide, iron, vascular endothelium and reperfusion injury. Free Radic Res Commun 1989; 5: 315-8
38. Castro L, Rodriguez M, Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor nitric oxide. J Biol Chem 1994; 269: 29409-15
39. Padmaja S, Huie RE. The reaction of nitric oxide with organic peroxyl radicals. Biochem Siophys Res Commun 1993; 195: 539-44
40. Beckman JS, Ye YZ, Anderson P et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 1994; 375: 81-8
41. Cabantchik ZI, Glickstein H, Milgram P, Breuer W. A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells. Anal Biochem 1996; 233: 221-7
42. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. J Biol Chem 1989; 264: 4417-22
43. Gutteridge JMC, Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J 1981; 199: 263-5
44. Mumby S, Koizumi M, Taniguchi N, Gutteridge JMC. Reactive iron species in biological fluids activate the iron-sulphur cluster of aconitase. Biochim Biophys Acta 1998; 1380: 102-8
45. De Silva DM, Askwith CC, Kaplan J. Molecular mechanisms of iron uptake in eukaryotes. Physiol Rev 1996; 76: 31-47
46. Klausner RD, Rouault A, Harford JB. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 1993; 72: 19-28
47. Kennedy MN, Mende-Mueller L, Blondin GA, Beinert H. Purification and characterisation of cytosolic aconitase from beef liver and its relationship to the iron-responsive element binding protein (IRE-BP). Proc Natl Acad Sci USA 1992; 89: 11730-4
48. Halliwell B, Gutteridge JMC. Lipid peroxidation, oxygen radicals, cell damage and anti-oxidant therapy. Lancet 1984; i: 1396-7
49. Herald M, Spiteller G. Enzymic production of hydroperoxides of unsaturated fatty acids by injury of mammalian cells. Chem Phys Lipids 1996; 79: 113-21
50. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128
51. 2 in relation to mammalian cell proliferation. Free Radic Biol Med 1994; 18: 775-94
52. Gutteridge JMC. Signal, messenger and trigger molecules from free radical reactions and their control by anti-oxidants. In: Packer L, Wirtz K (eds). Signalling mechanisms - from transcription factors to oxidative stress. Berlin: Springer, 1995; 157-64
53. Gutteridge JMC, Richmond R, Halliwell B. Oxygen free radicals and lipid peroxidation: inhibition by the protein caeruloplasmin. FEBS Lett 1980; 112: 269-72
54. Wolin MS. Reactive oxygen species and vascular signal transduction mechanisms. Microcirculation 1996; 3: 1-17
55. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9: 1319-30
56. Stone JR, Marletta MA. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide synthase. Biochemistry 1996; 35: 1093-9
57. Pollock JS, Forsterman U, Mitchell JA et al. Purification and characterisation of EDRF synthase. Proc Natl Acad Sci USA 1991; 89: 10480-5
58. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336: 385-8.
59. MacMicking M, Xie J, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323-50
60. Macnaughton PD, Evans TW. Adult respiratory distress syndrome. Lancet 1992; 339: 469-72
61. Ashbaugh DG, Biglow DB, Petty TL, Levine B. Active respiratory distress in adults. Lancet 1967; ii: 319-23
62. Gutteridge JMC, Quinlan GJ, Mumby S, Heath A, Evans TW. Primary plasma anti-oxidants in adult respiratory distress syndrome patients: changes in iron-oxidizing, iron-binding and free radical-scavenging proteins. J Lab Clin Med 1994; 124: 263-73
63. Gutteridge JMC, Quinlan GJ, Evans TW. Transient iron overload with bleomycin detectable iron in the plasma of patients with adult respiratory distress syndrome. Thorax 1994; 49: 707-10
64. Moak SA, Greenwald RA. Enhancement of rat serum ceruloplasmin levels by exposure to hyperoxia. Proc Soc Exp Biol Med 1984; 177: 97-103
65. Kresek-Staples JA, Kew RR, Webster RO. Ceruloplasmin and transferrin levels are altered in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1992; 145: 1009-15.
66. Fleming RE, Whitman IP, Gitlin JD. Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia. AmJ Physiol 1991; 260: L68-74
67. Quinlan GJ, Evans TW, Gutteridge JMC. Oxidative damage to plasma proteins in adult respiratory distress syndrome. Free Radic Res 1994; 20: 289-98
68. Paterson CE, Rhoades RA. Protective role of sulphydryl reagents in oxidant lung injury. Exp Lung Res 1988; 14: 1005-19
69. Bernard GR, Swindell BB, Meredith MJ, Carroll FE, Higgins SB. Glutathione (GSH) repletion by N-acetyl cysteine (NAC) in patients with the adult respiratory distress syndrome (ARDS). Am Rev Respir Dis 1989; 139: A221
70. Jepson S, Herlevsen P, Knudesen P, Bud MI, Klausen N-O. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective randomized placebo-controlled study. Crit Care Med 1992; 20: 918-23
71. Cross CE, Forte T, Stocker R et al. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med 1990; 115: 391-404
72. Frei B, Yamamoto Y, Niclas D, Stocker R, Cross CE, Ames B. Analysis of oxidants and antioxidants in human plasma of healthy subjects and of patients with adult respiratory distress syndrome. In: Rice-Evans C, Halliwell B (eds) Free radicals, methodology and concepts. London: Richelieu, 1988; 349-68
73. Bertrand Y, Pincemail J, Hanique G et al. Differences in tocopherol-lipid ratios in ARDS and non-ARDS patients. Intensive Care Med 1989; 15: 87-93
74. Baldwin SR, Grum CM, Boxer LA, Simon RH, Ketai LH, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986; i: 11-4
75. Sznajder JI, Fraiman A, Hall JB et al. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory falure. Chest 1989; 96: 602-12
76. Leff JA, Parson PE, Day CE et al. Increased serum catalase activity in septic patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1992; 146: 985-9
77. Leff JA, Parson PE, Day CE et al. Serum anti-oxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 1993; 341: 777-80
78. Gutteridge JMC, Mumby S, Quinlan GJ, Chung KF, Evans TW. Pro-oxidant iron is present in human pulmonary epithelial lining fluid: implications for oxidative stress in the lung. Biochem Biophys Res Commun 1996; 220: 1024-7
79. Pacht ER, Davis B. Role of transferrin and ceruloplasmin in anti-oxidant activity of lung epithelial lining fluid. J Appl Physiol 1988; 64: 2092-9
80. Quinlan GJ, Lamb NJ, Evans TW, Gutteridge JMC. Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. Crit Care Med 1996; 24: 241-6
81. Gutteridge JMC, Quinlan GJ, Yamamoto Y. Are fatty acid patterns characteristic of essential fatty acid deficiency indicative of oxidative stress? Free Radic Res 1998; 28: 109-14
82. Grum CM, Ragsdale RA, Ketai LH, Simon RH. Plasma xanthine oxidase activity in patients with adult respiratory distress syndrome. J Crit Care 1987; 2: 22-6
83. Quinlan GJ, Lamb NJ, Tilley R, Evans TW, Gutteridge JMC. Plasma hypoxanthine levels in ARDS: Implications for oxidative stress, morbidity and mortality. Am J Res Crit Care Med 1997; 155: 479-84
84. Ogilvie AC, Groeneveld AB, Straub JP, Thijs LG. Plasma lipid peroxides and anti-oxidants in human septic shock. Intensive Care Med 1991; 17: 40-4
85. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma anti-oxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 1996; 24: 1179-83
86. Galley HF, Howdle PD, Walker BE, Webster NR. The effects of intravenous anti-oxidants in patients with septic shock. Free Radic Biol Med 1997; 23: 768-74
87. Galley HF, Webster NR. Elevated serum bleomycin-detectable iron concentrations in patients with sepsis syndrome. Intensive Care Med 1996; 22: 226-9
88. Galley HF, Davies MJ, Webster NR. Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Radic Biol Med 1996; 20: 139-43
89. Mumby S, Margarson M, Quinlan GJ, Evans TW, Gutteridge JMC. Is bleomycin-detectable iron present in the plasma of patients with septic shock? Intensive Care Med 1997; 23: 635-9
90. Weinberg ED. The iron-with-holding defence system. Am Soc Microbiol News 1993; 59: 559-62
91. Lands WEM, Pendleton RB. Amplification of tissue peroxides in disease. In: Cerutti PA, Nygaard OF (eds) Anticarcinogenesis and radiation protection. New York: Plenum, 1987; 81-4
92. Quinlan GJ, Margarson M, Mumby S, Evans TW, Gutteridge JMC. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci 1998; 95: 459-65
93. Gutteridge JMC. Anti-oxidants, nutritional supplements and life-threatening diseases. Br J Biomed Sci 1994; 51: 288-95
94. Pepper JR, Mumby S, Gutteridge JMC. Sequential oxidative damage, and changes in iron-binding and iron-oxidising plasma anti-oxidants during cardiopulmonary bypass surgery. Free Radic Res 1994; 21: 377-85
95. Pepper JR, Mumby S, Gutteridge JMC. Transient iron-overload with bleomycin-detectable iron present during cardiopulmonary bypass surgery. Free Radic Res 1994; 21: 53-8
96. Messent M, Sinclair DG, Quinlan GJ, Mumby S, Gutteridge, Evans TW. Pulmonary vascular permeability after cardiopulmonary bypass and its relationship to oxidative stress. Crit Care Med 1997; 25: 425-9
97. Moat NE, Evans TW, Quinlan GJ, Gutteridge JMC. Chelatable iron and copper can be released from extracorporeally circulated blood during cardiopulmonary bypass. FEBS Lett 1993; 328: 103-6
98. Pepper JR, Mumby S, Gutteridge JMC. Blood cardioplegia increases plasma iron overload and thiol levels during cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 1735-40
99. Quinlan GJ, Mumby S, Pepper JR, Gutteridge JMC. Plasma 4-hydroxyl-2-nonenal levels during cardiopulmonary bypass and their relationship to the iron-loading of transferrin. Biochem Mol Biol Int 1994; 34: 1277-82
100. Quinlan GJ, Westerman ST. Mumby S, Pepper JR, Gutteridge JMC. Plasma hypoxanthine levels during crystalloid and blood cardioplegias: Warm blood cardioplegia increases hypoxanthine levels with a greater risk of oxidative stress. J Cardiavasc Surg 1999; 39: In press.
101. Gonzalez PK, Zhuang J, Doctrow SR et al. EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine. J Pharmacol Exp Ther 1995; 275: 798-806
102. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC. Placebo and inhaled nitric oxide mortality the same in ARDS clinical trial. Crit Care Med 198; 26: 619.
103. Treggiari-Venzi M, Ricou B, Romand JA, Suter PM. The response to repeated nitric oxide inhalation is consistent in patients with acute respiratory distress syndrome. Anesthesiology 1998; 88: 634-41
104. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 1997; 29: 159-66
105. Rose S, Sayeed MM. Superoxide radical scavenging prevents cellular calcium dysregulation during intraabdominal sepsis. Shock 1997; 7: 263-8
106. de Vos S, Epstein CJ, Carlson E, Cho SK, Koeffler HP. Transgenic mice overexpressing human copper/zinc-superoxide dismutase (Cu/Zn SOD) are not resistant to endotoxic shock. Biochem Biophys Res Commun 1995; 208: 523-31
107. Cochrane CG, Spragg RG, Revak SD, Cohen AB, McGuiree WW. The presence of neutrophil elastase and evidence of oxidation activity in bronchoalveolar lavage fluid of patients with adult respiratory syndrome. Am Rev Respir Dis 1983; 127: 25-7
108. Pacht ER, Timerman AP, Lykens MG et al. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991; 100: 1397-403
109. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4
110. Lamb NJ, Gutteridge JMC, Evans TW, Baker CS, Quinlan GJ. Increased levels of markers of oxidative damage are present in BAL fluid from patients with ARDS. Am J Respir Crit Care Med 1999; In press
111. Richard C, Lemonnier F, Thibault M, Auzepy P. Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome. Crit Care Med 1990; 18: 4-9
112. Quinlan GJ, Evans TW, Gutteridge JMC. 4-hydroxy-2-nonenal levels increase in the plasma of patients with adult respiratory distress syndrome as linoleic acid appears to fall. Free Radic Res 1994; 21: 95-106
113. Deby C. Difference in tocopherol-lipid ratios in ARDS and non-ARDS patients. Intensive Care Med 1989; 15: 877-93
114. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998; 317: 235-40
115. Offringa M. Excess mortality after human albumin administration in critically ill patients. BMJ 1998; 317: 223-4